2002/07/01 by Masao Yoshida, Kohei Takizawa, Satoru Nonaka +27 · 21 citations
Medicine · #Esophageal Cancer Research and Treatment #Gastric Cancer Management and Outcomes #Head and Neck Cancer Studies
paper · doi:10.1016/j.gie.2019.08.014
TA-ESD was superior to conventional ESD in terms of procedure duration and was not associated with any adverse events. TA-ESD should be considered the procedure of choice for large esophageal cancers. (Clinical trial registration number: UMIN000024080.).